In the midst of marijuana laws changing quickly across the United States, Pennsylvania has become the first state to permit medical marijuana research at some of its medical schools.
On Thursday, the Department of Health released the guidelines opening applications for medical research. Penn Medicine, Drexel University, and the University of the Sciences have all expressed interest in furthering medical marijuana research, according to NBC10.
According to Penn Live, the University of Pittsburgh School of Medicine was the first school to confirm their interest in the program.
“We believe that the research will be of great importance in determining the safety and efficacy of medical cannabis products in treating specific diseases,” the University of Pittsburgh wrote in a statement to NBC10.
Although Ohio and Florida have also looked into similar facets in their medical marijuana programs, neither state has yet to implement such a program, reported NBC10.
Up to eight medical schools could be granted approval for this research program. The state will begin to accept applications next month.
The Department of Health also announced the addition of 13 new medical marijuana growers and 23 new dispensaries in the state. The approved schools will work with authorized growers and dispensers to obtain marijuana for research.
The state approved its first medical marijuana dispenser in Bethlehem in January.
Even as PA. and other states have moved to expand their medical marijuana programs, the federal government has been attempting to stifle the ongoing legalization move.
In January, Attorney General Jeff Sessions rescinded an Obama-era policy which allowed states to regulate their own regulations concerning recreational use of the drug.
According to the DEA, marijuana is still considered a schedule I controlled substance “with no currently accepted medical use and a high potential for abuse” at a federal level. Other schedule I drugs include ecstasy and heroin.
Previous Penn affiliated studies have shown the usefulness of medical marijuana in treating addiction, particularly opioid addiction. Results of a 2014 study by Marcus A. Bachhuber noted a 25 percent decrease in deaths related to opioids in states that have legalized medical marijuana.
“People already taking opioids for pain may supplement with medical marijuana and be able to lower their painkiller dose, thus lowering their risk of overdose,” Bachhuber told PennMedicine News.
In Philadelphia, the District Attorney Larry Krasner recently announced that he had advised his staff to not pursue charges on people caught for marijuana possession. On campus, Penn’s policies on marijuana remain the same.